Skip to main content

Vaxxinity, Inc. (VAXX)

NASDAQ: VAXX · IEX Real-Time Price · USD
12.75 0.31 (2.49%)
Dec 1, 2021 12:44 PM EST - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year20202019
Revenue
0.560
Cost of Revenue
0.050
Gross Profit
0.510
Selling, General & Admin
12.223.01
Research & Development
20.5710.66
Operating Expenses
32.7913.66
Operating Income
-32.28-13.66
Interest Expense / Income
1.180.44
Other Expense / Income
6.490.07
Pretax Income
-39.96-14.16
Income Tax
00.06
Net Income
-39.96-14.22
Net Income Common
-39.96-14.22
Shares Outstanding (Basic)
10253
Shares Outstanding (Diluted)
10253
Shares Change
91.87%-
EPS (Basic)
-0.39-0.27
EPS (Diluted)
-0.39-0.27
Free Cash Flow Per Share
-0.35-0.23
Gross Margin
90.66%-
Operating Margin
-5795.69%-
Profit Margin
-7173.61%-
Free Cash Flow Margin
-6353.14%-
Effective Tax Rate
0.00%-0.40%
EBITDA
-38.06-13.62
EBITDA Margin
-6832.85%-
EBIT
-38.78-13.73
EBIT Margin
-6961.58%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).